Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
03/2004
03/25/2004US20040059137 Method for producing compounds having a cf2o bridge
03/25/2004US20040059083 Low corrosive integrated process for preparing dialkyl carbonates
03/25/2004US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use
03/25/2004US20040058988 Fatty acid synthase inhibitors
03/24/2004EP1399406A2 Novel estrogen receptor ligands and methods i
03/24/2004EP1399148A2 Multifunctional carbonates and derivatives
03/24/2004EP1399137A1 Sulfonamides
03/24/2004CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use
03/23/2004US6710088 Inorganic ion receptor-active compounds
03/23/2004US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives
03/23/2004CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them
03/23/2004CA2101575C New cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2003099192A3 Bis-aromatic alkanols
03/18/2004WO2003097576A3 Diamino-functional chalcones
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040054214 Reacting alkylene oxide, carbon dioxide and alcohol using carbonation catalyst
03/18/2004US20040054196 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
03/18/2004US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
03/18/2004US20040053994 Laetispicine and laetispicine analogues, methods of use and preparation
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053158 Onium salts and the use therof as latent acids
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/17/2004EP1397369A1 New use or cyclolignans and new cyclolignans
03/17/2004EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004CN1142156C Cyclic cedrene aldehyde acetal, its preparation and its use
03/16/2004US6706899 Acyclic chiral compound from garcinia acid and process for preparing the same
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
03/16/2004US6706338 Liquid-crystalline compounds
03/11/2004WO2004020481A1 Fulvene, metallocene catalysts and preparation method thereof, and preparation of polyolefines copolymer using the same
03/11/2004WO2004020429A1 Kinetic resolution method
03/11/2004WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004US20040049056 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions.
03/11/2004US20040048835 7-Substituted fused ring tetracycline compounds
03/11/2004US20040046150 Liquid-crystalline media comprising at least compound of the formula I and to electro-optical displays containing a liquid-crystalline medium of this type.
03/11/2004CA2495448A1 Kinetic resolution method
03/11/2004CA2464518A1 Fulvene, metallocene catalysts and preparation method thereof, and preparation of polyolefines copolymer using the same
03/10/2004EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
03/10/2004CN1481376A Oxybenzamides derivatives as factor xa inhibitors
03/10/2004CN1480455A 'Sqiqu site' ramification and its preparing method as well as its activity of anti asthma
03/10/2004CN1141295C Indoline derivatives as progesterohe antagonists
03/04/2004WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
03/04/2004WO2004018416A1 4-[(alkylsulfanyl)methyl]-1, 2-benzenediol, preparation method thereof and antioxidant containing the same
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004WO2004018410A1 Substituted benzanilide compound and pest control agent
03/04/2004US20040044233 Nucleophilic kinetic resolution of cyclic substrates using silyl azides
03/04/2004US20040044075 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
03/04/2004US20040044049 Compounds for inhibiting insulin secretion and methods related thereto
03/04/2004US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/04/2004US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine
03/04/2004US20040043917 Oxime methyl ethers
03/03/2004EP1392690A2 Novel processes for the preparation of adenosine compounds and intermediates thereto
03/03/2004EP1392673A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/03/2004EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
03/03/2004EP1392650A2 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2- ?18 f]-fluoroethyl)-l-tyrosine
03/03/2004EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators
03/03/2004EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
03/03/2004EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF
03/03/2004CN1479703A Method for producing compounds having CF2O bridge
03/03/2004CN1478785A Antitumour platinum (II) compound using camphor acid radical as ligand
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140523C Method for synthesizing beta-biphenyl diester
03/02/2004US6699994 Biaryl compounds as serine protease inhibitors
03/02/2004US6699951 Monomer and polymer for photoresist, photoresist composition, and phosphor layer composition for color cathode ray tube
03/02/2004US6699911 Preparation of cyclohexene derivatives intermediates for carotinoids using a mixture of zinc and a salt of ammonium, copper, alkali metal or alkaline earth metal as reducing agent
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699891 Npyy5 antagonists
03/02/2004US6699890 Phosphodiesterase 4 inhibitors
03/02/2004US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration
02/2004
02/26/2004WO2003097575A3 Amino-functional chalcones
02/26/2004WO2003097574A3 Aminoalkoxy-functional chalcones
02/26/2004US20040039053 Administering to a patient a (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives or salt, free of its (+) stereoisomer to treat the type II diabetes, gout, insulin resistance and atherosclerosis
02/26/2004US20040039016 HIV protease inhibitors
02/26/2004US20040038989 (S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals, useful as intermediates for the preparation of levodropropizine
02/26/2004US20040038977 Treating arthritis, pain and cancer
02/26/2004US20040038941 Compounds for the treatment of inflammatory disorders
02/26/2004US20040038268 Support bound probes and methods of analysis using the same
02/26/2004DE10325697A1 Hydrogenation of fluorine-containing cyclohexene derivatives, useful in preparation of liquid crystal materials, in presence of basic ion exchanger that inhibits defluorination
02/25/2004EP1005446B1 N-aroylphenylalanine derivatives
02/25/2004EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
02/25/2004CN1139587C Cosmetic preparation containing light stable UV-A light filter agent
02/25/2004CN1139586C Process for stereoselective preparation of hetero-bicyclic alcohol enantiomer
02/25/2004CN1139585C Preparation method of vinylene carbonate and its application
02/24/2004US6696579 Improving color and color stability; removing impurities using silica or alumina adsorbent
02/24/2004US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives
02/24/2004US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
02/24/2004CA2332847C Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof
02/24/2004CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
02/19/2004WO2004014966A1 Microstructure chain transfer agents for anionic polymerization
02/19/2004WO2004014888A1 Endiandric acid h derivatives as c-maf inhibitors for using against asthma
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 183